Qiongyao Wang

253 Gongye Road
Guangzhou, 510282, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Targeting FOXP1 phase separation in small cell lung cancer mechanisms of chemotherapy resistance.

Targeting FOXP1 phase separation in small cell lung cancer mechanisms of chemotherapy resistance.

Journal: Communications biology

Published: August 07, 2024

CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer.

CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 18, 2024

Correction for: ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.

Correction for: ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.

Journal: Aging

Published: January 13, 2024

Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer.

Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 02, 2022

METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.

METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 10, 2022

Identifying CDC7 as a synergistic target of chemotherapy in resistant small-cell lung cancer via CRISPR/Cas9 screening.

Identifying CDC7 as a synergistic target of chemotherapy in resistant small-cell lung cancer via CRISPR/Cas9 screening.

Journal: Cell death discovery

Published: October 09, 2022

Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated SOX2 methylation.

Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated SOX2 methylation.

Journal: Cancer science

Published: July 12, 2022

lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy.

lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 25, 2022

Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC.

Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 02, 2022

NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process.

NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process.

Journal: iScience

Published: November 04, 2021

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.

Journal: Frontiers in cell and developmental biology

Published: August 11, 2021

WITHDRAWN: lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy.

WITHDRAWN: lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 06, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026